Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8405818rdf:typepubmed:Citationlld:pubmed
pubmed-article:8405818lifeskim:mentionsumls-concept:C0039231lld:lifeskim
pubmed-article:8405818lifeskim:mentionsumls-concept:C0036043lld:lifeskim
pubmed-article:8405818lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:8405818lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:8405818lifeskim:mentionsumls-concept:C2350239lld:lifeskim
pubmed-article:8405818lifeskim:mentionsumls-concept:C0439834lld:lifeskim
pubmed-article:8405818lifeskim:mentionsumls-concept:C1280519lld:lifeskim
pubmed-article:8405818lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:8405818lifeskim:mentionsumls-concept:C0443268lld:lifeskim
pubmed-article:8405818pubmed:issue6lld:pubmed
pubmed-article:8405818pubmed:dateCreated1993-10-25lld:pubmed
pubmed-article:8405818pubmed:abstractTextVarious ablation methods have been proposed in the last few years in order to find a radical solution for atrioventricular nodal reentrant tachycardia. The first techniques were surgical, followed by modulation of the fast pathway, causing a prolongation of the P-R interval, the latter involving a 2 to 10% atrioventricular block risk. To reduce this risk, slow pathway ablation was then suggested, with the objective of abolishing atrioventricular reentry. The aim of our study was to evaluate how frequently the recording of peculiar slow potentials was possible in patients with atrioventricular nodal reentrant tachycardia, and to assess short-and long-term efficacy of an ablation technique involving the use of these potentials as electrophysiologic markers.lld:pubmed
pubmed-article:8405818pubmed:languageitalld:pubmed
pubmed-article:8405818pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8405818pubmed:citationSubsetIMlld:pubmed
pubmed-article:8405818pubmed:statusMEDLINElld:pubmed
pubmed-article:8405818pubmed:monthJunlld:pubmed
pubmed-article:8405818pubmed:issn0046-5968lld:pubmed
pubmed-article:8405818pubmed:authorpubmed-author:RiccardiRRlld:pubmed
pubmed-article:8405818pubmed:authorpubmed-author:GaitaFFlld:pubmed
pubmed-article:8405818pubmed:authorpubmed-author:WarinJ FJFlld:pubmed
pubmed-article:8405818pubmed:authorpubmed-author:HaissaguerreM...lld:pubmed
pubmed-article:8405818pubmed:authorpubmed-author:BocchiardoMMlld:pubmed
pubmed-article:8405818pubmed:authorpubmed-author:RichiardiEElld:pubmed
pubmed-article:8405818pubmed:authorpubmed-author:ScaglioneMMlld:pubmed
pubmed-article:8405818pubmed:authorpubmed-author:Di DonnaPPlld:pubmed
pubmed-article:8405818pubmed:issnTypePrintlld:pubmed
pubmed-article:8405818pubmed:volume23lld:pubmed
pubmed-article:8405818pubmed:ownerNLMlld:pubmed
pubmed-article:8405818pubmed:authorsCompleteYlld:pubmed
pubmed-article:8405818pubmed:pagination563-74lld:pubmed
pubmed-article:8405818pubmed:dateRevised2010-3-24lld:pubmed
pubmed-article:8405818pubmed:meshHeadingpubmed-meshheading:8405818-...lld:pubmed
pubmed-article:8405818pubmed:meshHeadingpubmed-meshheading:8405818-...lld:pubmed
pubmed-article:8405818pubmed:meshHeadingpubmed-meshheading:8405818-...lld:pubmed
pubmed-article:8405818pubmed:meshHeadingpubmed-meshheading:8405818-...lld:pubmed
pubmed-article:8405818pubmed:meshHeadingpubmed-meshheading:8405818-...lld:pubmed
pubmed-article:8405818pubmed:meshHeadingpubmed-meshheading:8405818-...lld:pubmed
pubmed-article:8405818pubmed:meshHeadingpubmed-meshheading:8405818-...lld:pubmed
pubmed-article:8405818pubmed:meshHeadingpubmed-meshheading:8405818-...lld:pubmed
pubmed-article:8405818pubmed:meshHeadingpubmed-meshheading:8405818-...lld:pubmed
pubmed-article:8405818pubmed:meshHeadingpubmed-meshheading:8405818-...lld:pubmed
pubmed-article:8405818pubmed:meshHeadingpubmed-meshheading:8405818-...lld:pubmed
pubmed-article:8405818pubmed:meshHeadingpubmed-meshheading:8405818-...lld:pubmed
pubmed-article:8405818pubmed:meshHeadingpubmed-meshheading:8405818-...lld:pubmed
pubmed-article:8405818pubmed:meshHeadingpubmed-meshheading:8405818-...lld:pubmed
pubmed-article:8405818pubmed:meshHeadingpubmed-meshheading:8405818-...lld:pubmed
pubmed-article:8405818pubmed:meshHeadingpubmed-meshheading:8405818-...lld:pubmed
pubmed-article:8405818pubmed:meshHeadingpubmed-meshheading:8405818-...lld:pubmed
pubmed-article:8405818pubmed:year1993lld:pubmed
pubmed-article:8405818pubmed:articleTitle[Nodal reentry tachycardia: short- and long-term effectiveness and safety of a selective ablation technique of the slow pathway].lld:pubmed
pubmed-article:8405818pubmed:affiliationDivisione di Cardiologia dell'Ospedale di Asti, Bordeaux, France.lld:pubmed
pubmed-article:8405818pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8405818pubmed:publicationTypeEnglish Abstractlld:pubmed